pentobarbital will lower the level or outcome of repaglinide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.

pentobarbital will decrease the extent or outcome of finasteride by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Unidentified.

pentobarbital will minimize the extent or impact of oliceridine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of. If coadministration which has a CYP3A4 inducer is necessary, look at expanding oliceridine dose right until steady drug effects are attained; observe for signs of opioid withdrawal.

pentobarbital decreases amounts of atrasentan by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Stay clear of or Use Alternate Drug. Coadministration with robust or reasonable CYP3A inducers is anticipated to decrease atrasentan systemic publicity, which can lower efficacy. .

pentobarbital will lower the extent or influence of siponimod by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Coadministration of siponimod that has a drug that causes moderate CYP2C9 in addition a reasonable or solid CYP3A4 inducer is just not advised.

pentobarbital will lessen the extent or impact of etravirine by affecting hepatic enzyme CYP2C9/ten metabolism. Use Warning/Watch.

Psychological, tolerance and Bodily dependence might manifest with continued use; individuals with psychological dependence on barbiturates could acquire a Bodily dependence on barbiturates by escalating or decreasing the dosage interval without having consulting a doctor

pentobarbital will reduce the level or outcome of nimodipine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unknown.

pentobarbital will lessen the extent or impact of loratadine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.

pentobarbital will raise the level or outcome of ivosidenib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Coadministration of ivosidenib with sturdy CYP3A4 inducers lowered ivosidenib plasma concentrations.

pentobarbital will lessen the level or effect of diazepam buccal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch. Powerful or moderate CYP3A4 inducers might enhance fee of diazepam elimination; consequently, efficacy of diazepam may very well be decreased.

pentobarbital will lower here the level or outcome of stiripentol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. If struggling to steer clear of coadministration of stiripentol with robust CYP3A4 inducers, increase stiripentol dose.

pentobarbital will increase toxicity of ifosfamide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of. CYP3A4 inducers may possibly improve the metabolism of ifosfamide to its Lively alkylating metabolites.

This drug might interfere Using the absorption of orally administered griseofulvin, reducing its blood ranges; outcomes of blood degree reduction mysterious; preferable to stay away from concomitant administration of these medications